Herdin Record #:
A randomized controlled trial on the use of virgin coconut oil in augmenting weight gain among infants weighing 1500 grams or less: Preliminary results.
|1Jacinto Blas V. Mantaring III
|2Maribel R. Amante-Aurelio
| University of the Philippines-Philippine General Hospital Medical Center
Publication Sub Type:
Journal Article, Original
Philippine Journal of Pediatrics
The Philippine Pediatric Society, Inc.
The objective of this investigation is to determine if low birth weight neonates (weighing <1500 g) who are given virgin coconut oil as a supplement to their breastmilk or preterm formula will have better weight gain compared to neonates without such supplementation.
Specifically, it was done (1) to determine if there is a difference in weight gain (grams/day) of infants receiving breastmilk or preterm formula supplemented with 0.5 ml virgin nut oil per ounce of milk compared to infants receiving breastmilk or preterm formula alone; (2) to determine if there is a difference in the occurrence of vomiting, diarrhea, abdominal distension and feeding residuals in the two treatment groups; (3) to determine if there is a difference in the duration of intervention between low birth weight infants among the two treatment groups; and (4) to determine the difference in the occurrence of nosocomial infections such as sepsis, pneumonia, urinary tract infection, meningitis and necrotizing enterocolitis, and deaths between the two treatment groups.
RATIONALE. Medium chain triglyceride (MCT) oil is used to augment weight gain of low birth weight infants. However, it is commercially unavailable. Coconut oil contains the most concentrated, natural source of MCT and lauric acid which provides antibacterial properties.
PRIMARY OBJECTIVE. To determine if neonates weighing < / - 1500 g given virgin coconut oil (VCO) will have better weight gain compared to neonates without such supplementation.
DESIGN. Triple-blind, randomized controlled trial.
SETTING. Neonatal intensive care unit of a tertiary government hospital.
PATIENTS AND METHODS. Neonates with birth weight <1500 g; able to tolerate at least 50 ml/kg/day of enteral feedings, and with informed consent were included. Subjects were randomized into either treatment or control group. Both groups received preterm formula or breastmilk. VCO was added at 0.5 ml/oz to the feedings of the treatment group. The outcomes were analyzed by intention to treat. A p-value <0.05 was considered statistically significant. The difference in weight gain, duration of intervention, the occurrence of feeding intolerance and sepsis were among those measured.
RESULTS. Ninety neonates (46 in the treatment group, 44 in the control group) were included. The baseline characteristics had no statistical difference except for birth head circumference (p=0.04) and entry mid-upper arm circumference (p=0.03) which were both higher in the treatment group. There was a trend towards higher weight gain per day (27.1 +/- 16.8 vs. 22.1 +/- 117.1, p=0.666) and other growth parameters, and shorter duration of intervention in the treatment group. There were fewer adverse events in the treatment group. Sepsis was lower in the treatment group, and this was statistically significant (p=0.008).
CONCLUSION. This interim analysis shows a trend towards an increase in weight gain and other growth parameters among those whose feedings were augmented with VCO. The occurrence of feeding intolerance and sepsis were also lower in the treatment group. To reach statistical power, the study is ongoing. (Author)
|Location||Call Number||Available Format||Availability|
|Philippine Council for Health Research and Development Library
||Box No. 66
||Print Format (Request Document)
1. Joshi S, . Feeding in the Low Birth Weight Newborns. Available from: . http://www.pediatriconcall. com/fordoctor/Diseasesand-Condition/feed_low_weight. asp.
2. Diehl-Jones WL, , Askin DE, . "Nutritional Modulation of Neonatal Outcomes" AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15(1): 83-96, January 2004
3. Yuen DE, , Churcher E, , Sweft W et al., . Protocol for Enteral Nutrition of Neonates. University of Ottawa and Children's Hospital of eastern Ontario, Ontario, Canada, April, 1998.
4. Lee JS, , Polin RA, . "Treatment and Prevention of Necrotizing Enterocolitis" Semin Neonatol 8(6): 449-459, December 2003
5. Behrman RE, , Kliegman RM, , Jenson HB, . Nelson Textbook of Pediatrics. Philadelphia, Pennsylvania: Saunders, 2004. 628. (17th ed)
6. Estrella MCP, , Mantaring JBV, . A Double-Blind, Randomized Controlled Trial on the Effect of Trophic Feeding Using Exclusive Breastmilk Among Preterms <35 Weeks Age of Gestation on Neoonatal Sepsis and Mortality. Unpublished 2003.
7. Fife B, . The Health Benefits of Medium Chain Fatty Triglycerides. In: Fife B. The Healing miracles of Coconut Oil New York, USA: Avery, 2001.
8. Fife B, . Coconut Oil: A Low-Calorie Fat. In: Fife B. The Healing miracles of Coconut Oil New York, USA: Avery, 2001.
9. Dayrit CS, . Coconut for Better Health. Unpublished 2004.
10. Byrnes S, . I've Got a lovely bunch of Coconuts: Coconut Holds Promise for Immune Suppressed People. Available from. http://www.powerhealth.net/articlecoconut.htm [accessed 2004 Oct. 12].
11. Estrellado WLC, . "Ramdomized Controlled Trial on the Use of Medium Chain Triglyceride-Supplemented Premature Milk Formula in Augmenting Weight Gain Among Infants Less Than 35 Weeks Gestation" Philipp J Pediatr 8(4): 224-227, December 1999
12. Vaidya UV, , Hegde VM, , Bhave SA et al, . "Vegetable Oil Fortified Feeds in the Nutrition of Very Low Birth Weight Babies" Indian Pediatr 29(12): 1519-27, December 1992
13. Coconut Oil Facts. United Coconut Association of the Philippines, Inc.,
14. Fife B, . Understanding Fats. In: Fife, B. The Coconut Oil Miracle New York, USA: Avery, 2004. 17-35.
15. Dayrit CS, . Coconut for Better Health. Unpublished 2004.
16. Enig MG, . Coconut: In Support of Good Health for the 21st Century. Available from. http://www.apcc. org.sg/specil.htm [accessed 2004 Oct 14].
17. Dayrit CS, . Coconut for Better Health. Unpublished 2004.
18. Bergsson G, , Arnfinnson J, , Steingrimsson O et a, . "Killing of Grampositive Cocci by Fatty Acids and Monoglycerides" APMIS 109(10): 670-678, September 2001
19. Bergsson G, , Arnfinnson J, , Steingrimsson O et a, . "In Vitro Killing of Candida albicans by Fatty Acids and Monoglycerides" Antimicob Agents Chemother 45(11): 3209-3212, November 2001
20. Isaacs CE, , Litov RE, , Thormar H, . "Antimicrobial Activity of Lipids Added to Human Milk, Infant Formula, and Bovine Milk" J Nutr Biochem 6(7): 362-366, July 1995
21. Teaching Files: Necrotizing Enterocolitis (NEe). Available from. http://www.neonatology.org/ syllablus/nec.htm1 [accessed 2004 Apr 18).
22. Garner JS et al, . CDC definitions for nosocomial infections. In: Olmsted RN, ed.: APIC Infection Control and Applied Epidemiology: Principles and Practice St. Louis: Mosby, 1996.
23. Bravo LC, , Gatchalian SR, , Conzales MLM et al., . A Guide to Pediatric Infection Control. Manila: Philippine General Hospital, 2001.
24. Garner JS et al, . CDC definitions for nosocomial infections. In: Olmsted RN, ed.: APIC Infection Control and Applied Epidemiology: Principles and Practice St. Louis: Mosby, 1996.
25. Joshi S, . Feeding in the Low Birth Weight Newborns. Available from. http://www.pediatriconcall. com/fordoctor/diseasesandcondition/feed_low_weight.asp.
26. Estrellado WLC, . "Randomized Controlled Trial on the Use of Medium Chain Triglyceride-Supplemented Premature Milk Formula in Augmenting Weight Gain Among Infants Less Than 35 Weeks Gestation" J Pediatr 8(4): 224-227, December 1999
27. Teaching Files: Necrotizing Enterocolitis (NEC). Available from. http://www.neonatology.org/ syllabus/nec.html [accessed 2004 Apr 18].
28. Kabara JJ, . Health Oils from the Tree of Life: Nutritional and Health Aspects from the Tree of Life. Available from. www.coconutoil.com/John%20Kabara.pdf.
29. Thormar H, , Isaacs CE, , Brown HR, , Barshtzky MR, , Pessolano T, . "Inactivation of Enveloped Viruses and Killing of Cells by Fatty Acids and Monoglycerides" Antimicrob Agents Chemother 31(1): 27-31, January 1987
30. Projan SJ, , Brown-Skrobot S, , Schlievert PM, . "Glycerol monolaurate inhibits the production of betalactamase, toxic-shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction" J Bacteriol 176(14): 4204-9, July 1994
31. Enig MG, . "Health and Nutritional Benefits from Coconut Oil: An Important Functional Food for the 21 st Century" Proceedings of the AVOC Lauric Oils Symposium; Apr 25, 1996. Ho Chi Min City, Vietnam: Available at: www. westonaprice.org/ know_your_fats/coconut_oil.html,
32. Fife B, . Nature's Marvelous germ Fighter. In: Fife, B. The Coconut Oil Miracle New York, USA: Avery;, 2004. 59-84.
33. Bergsson G, , Arnfinnson J, , Steingrimsson O, , Thormar H, . "In Vitro Killing of Candida albicans by Fatty Acids and Monoglycerides" Antimicrob Agents Chemother 45(11): 3209-3212, November 2001
34. Behrman RE, , Kliegman RM, , Jenson HB, . Nelson Textbook of Pediatrics. Philadelphia, Pensylvania: Saunders, 2004. 626-630. (17th ed)